Aerosol chemo trial aims to extend life for inoperable cancer patients
NCT ID NCT03875144
Summary
This study is testing whether adding a new pressurized aerosol chemotherapy (PIPAC) directly into the abdomen, along with standard intravenous chemotherapy, works better than standard IV chemo alone for people with advanced peritoneal mesothelioma who cannot have surgery. The main goal is to see if this combination helps patients live longer. The trial is currently suspended and was planned for 66 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut réginal du Cancer de Montpellier
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.